Loading clinical trials...
Loading clinical trials...
The purpose of this study is to decide if controlling stomach acid is related to healing of erosive esophagitis after treatment with esomeprazole magnesium (NEXIUM®) 10 mg and 40 mg once daily.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
AstraZeneca
NCT05514769 · Proximal Gastric Adenocarcinoma, Gastric Cancer, and more
NCT02616302 · Gastroesophageal Reflux Disease (GERD)
NCT07010107 · Reflux Esophagitis (RE)
NCT07121803 · Ineffective Esophageal Motility, GERD (Gastroesophageal Reflux Disease)
NCT06926374 · Colorectal Carcinoma, Rectal Prolapse, and more
Research Site
Alabaster, Alabama
Research Site
Anaheim, California
Research Site
Dinuba, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions